Harmony Biosciences (HRMY) Short Interest Ratio & Short Volume $30.32 +0.46 (+1.54%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$30.86 +0.54 (+1.78%) As of 05/2/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Harmony Biosciences Short Interest DataHarmony Biosciences (HRMY) has a short interest of 3.25 million shares, representing 7.46% of the float (the number of shares available for trading by the public). This marks a -6.88% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 574,483 shares to cover all short positions.Current Short Interest3,250,000 sharesPrevious Short Interest3,490,000 sharesChange Vs. Previous Month-6.88%Dollar Volume Sold Short$93.44 millionShort Interest Ratio4.7 Days to CoverLast Record DateApril 15, 2025Outstanding Shares57,387,000 sharesFloat Size43,540,000 sharesShort Percent of Float7.46%Today's Trading Volume857,912 sharesAverage Trading Volume574,483 sharesToday's Volume Vs. Average149% Short Selling Harmony Biosciences? Sign up to receive the latest short interest report for Harmony Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHRMY Short Interest Over TimeHRMY Days to Cover Over TimeHRMY Percentage of Float Shorted Over Time Harmony Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20253,250,000 shares $93.44 million -6.9%7.5%4.7 $28.75 3/31/20253,490,000 shares $115.83 million -15.1%8.0%5.1 $33.19 3/15/20254,110,000 shares $134.48 million +5.4%9.5%6.1 $32.72 2/28/20253,900,000 shares $132.02 million +4.0%9.0%6.3 $33.85 2/15/20253,750,000 shares $146.18 million -0.5%8.7%6.5 $38.98 1/31/20253,770,000 shares $146.16 million -31.8%9.3%7 $38.77 1/15/20255,530,000 shares $204.22 million -3.2%13.7%7.3 $36.93 12/31/20245,710,000 shares $196.48 million +5.0%14.1%7.7 $34.41 12/15/20245,440,000 shares $176.20 million -0.2%13.4%7 $32.39 11/30/20245,450,000 shares $188.95 million -6.0%13.5%7.3 $34.67 Get the Latest News and Ratings for HRMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harmony Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/20245,800,000 shares $192.65 million -4.3%14.3%8 $33.22 10/31/20246,060,000 shares $194.71 million -18.7%15.2%8.9 $32.13 10/15/20247,450,000 shares $264.48 million -12.8%24.3%16.9 $35.50 9/30/20248,540,000 shares $341.60 million +1.6%27.8%19.8 $40.00 9/15/20248,410,000 shares $327.23 million -4.0%27.4%21.4 $38.91 8/31/20248,760,000 shares $315.18 million +0.3%28.6%23.5 $35.98 8/15/20248,730,000 shares $307.73 million +3.9%28.5%24 $35.25 7/31/20248,400,000 shares $284.42 million +4.2%27.4%22.4 $33.86 7/15/20248,060,000 shares $274.12 million -3.1%26.3%20 $34.01 6/30/20248,320,000 shares $251.01 million +2.3%27.2%20.4 $30.17 6/15/20248,130,000 shares $236.18 million +17.2%26.5%21.2 $29.05 5/31/20246,940,000 shares $204.04 million -2.1%22.7%17.4 $29.40 5/15/20247,090,000 shares $210.57 million +5.5%23.1%17.1 $29.70 4/30/20246,720,000 shares $207.72 million +4.0%16.1%15.9 $30.91 4/15/20246,460,000 shares $190.70 million +1.7%21.0%17.6 $29.52 3/31/20246,350,000 shares $213.23 million +4.3%20.7%17.5 $33.58 3/15/20246,090,000 shares $194.76 million -3.2%19.8%16.9 $31.98 2/29/20246,290,000 shares $201.91 million -1.9%19.9%15.4 $32.10 2/15/20246,410,000 shares $224.73 million +0.9%20.3%15.1 $35.06 1/31/20246,350,000 shares $200.28 million +1.6%19.5%13.8 $31.54 1/15/20246,250,000 shares $195.75 million +3.5%19.2%10.7 $31.32 12/31/20236,040,000 shares $195.09 million +2.4%18.6%8 $32.30 12/15/20235,900,000 shares $198.65 million -0.8%18.1%7.8 $33.67 11/30/20235,950,000 shares $172.91 million +0.3%17.9%7.6 $29.06 11/15/20235,930,000 shares $149.44 million +11.1%17.9%7.4 $25.20 10/31/20235,340,000 shares $125.70 million -22.6%16.1%6.8 $23.54 10/15/20236,900,000 shares $145.66 million -1.6%20.3%9.4 $21.11 9/30/20237,010,000 shares $229.72 million -4.6%20.6%12.4 $32.77 9/15/20237,350,000 shares $275.77 million -5.0%21.6%13.8 $37.52 8/31/20237,740,000 shares $280.58 million +3.8%22.8%15.7 $36.25Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 8/15/20237,460,000 shares $245.36 million -2.1%22.0%16.6 $32.89 7/31/20237,620,000 shares $269.52 million -8.5%22.6%16.7 $35.37 7/15/20238,330,000 shares $294.47 million -1.2%24.7%16.7 $35.35 6/30/20238,430,000 shares $296.65 million +2.9%25.0%15.7 $35.19 6/15/20238,190,000 shares $297.05 million +2.1%24.3%9.6 $36.27 5/31/20238,020,000 shares $277.33 million +0.6%23.9%9.2 $34.58 5/15/20237,970,000 shares $291.22 million -2.3%23.8%8.5 $36.54 4/30/20238,160,000 shares $263.08 million +2.1%24.4%8.6 $32.24 4/15/20237,990,000 shares $251.76 million +7.0%24.1%8.9 $31.51 3/31/20237,470,000 shares $243.90 million +19.0%22.6%8 $32.65 3/15/20236,280,000 shares $255.22 million +8.3%19.0%10.6 $40.64 2/28/20235,800,000 shares $255.37 million +8.0%17.5%10.5 $44.03 2/15/20235,370,000 shares $262.16 million +5.5%16.3%10.2 $48.82 1/31/20235,090,000 shares $245.19 million -3.8%15.5%10.7 $48.17 1/15/20235,290,000 shares $250.85 million +21.1%16.2%10.5 $47.42 12/30/20224,370,000 shares $240.79 million +9.3%13.3%8.9 $55.10 12/15/20224,000,000 shares $224.52 million -26.1%12.5%8.8 $56.13 11/30/20225,410,000 shares $323.36 million -4.6%17.0%10.9 $59.77 11/15/20225,670,000 shares $318.09 million -1.7%17.8%11.5 $56.10 10/31/20225,770,000 shares $300.04 million +0.2%18.5%11.3 $52.00 10/15/20225,760,000 shares $294.16 million -5.0%18.5%10.8 $51.07 9/30/20226,060,000 shares $268.40 million +5.6%19.5%11.2 $44.29 9/15/20225,740,000 shares $257.96 million +9.5%18.5%10.1 $44.94 8/31/20225,240,000 shares $230.09 million +2.8%16.9%9.6 $43.91 8/15/20225,100,000 shares $259.59 million +3.0%16.4%9.4 $50.90 7/31/20224,950,000 shares $251.11 million +5.8%16.6%9.2 $50.73 7/15/20224,680,000 shares $251.08 million +6.6%15.7%8.9 $53.65 6/30/20224,390,000 shares $214.10 million +6.3%14.8%8.2 $48.77 6/15/20224,130,000 shares $184.24 million +2.0%14.1%7.9 $44.61 5/31/20224,050,000 shares $176.58 million +1.0%13.8%7.7 $43.60 5/15/20224,010,000 shares $152.30 million +2.6%13.7%7.4 $37.98 4/30/20223,910,000 shares $176.11 million +3.7%14.1%7.6 $45.04 4/15/20223,770,000 shares $194.31 million +3.6%13.7%8.4 $51.54 3/31/20223,640,000 shares $177.09 million +1.4%N/A9.3 $48.65 3/15/20223,590,000 shares $157.31 million +7.2%13.7%9.4 $43.82 2/28/20223,350,000 shares $133.87 million +2.1%12.7%9.3 $39.96 2/15/20223,280,000 shares $130.38 million +10.8%12.6%10.4 $39.75 1/31/20222,960,000 shares $106.15 million -10.0%14.1%9 $35.86 1/15/20223,290,000 shares $120.68 million +10.8%N/A0 $36.68 12/31/20212,970,000 shares $126.64 million -2.9%12.0%6.1 $42.64 12/15/20213,060,000 shares $120.50 million -5.0%12.4%6.4 $39.38 11/30/20213,220,000 shares $109.77 million +22.0%12.9%6.2 $34.09 11/15/20212,640,000 shares $108.27 million +3.5%10.6%5 $41.01 10/29/20212,550,000 shares $105.75 million +94.7%11.6%4.8 $41.47 10/15/20211,310,000 shares $51.61 million -7.1%6.0%2.6 $39.40 9/30/20211,410,000 shares $54.05 million +52.1%6.4%4 $38.33 9/15/2021927,100 shares $33.70 million -4.9%4.1%2.6 $36.35 8/31/2021974,500 shares $33.03 million -10.6%4.3%3.4 $33.89 8/13/20211,090,000 shares $35.04 million +2.8%4.8%3.9 $32.15 7/30/20211,060,000 shares $27.73 million +16.6%4.9%3.7 $26.16Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 7/15/2021908,800 shares $26.36 million -1.2%4.2%3.4 $29.01 6/30/2021919,700 shares $25.96 million +53.9%4.2%3.7 $28.23 6/15/2021597,700 shares $18.97 million -6.3%2.8%2.9 $31.73 5/28/2021638,000 shares $20.39 million +7.7%2.9%3 $31.96 5/14/2021592,500 shares $15.46 million +20.3%2.9%3.2 $26.10 4/30/2021492,500 shares $14.29 million +61.9%1.7%3.5 $29.01 4/15/2021304,300 shares $8.85 million -54.1%1.1%2.4 $29.08 3/31/2021663,200 shares $21.24 million +7.5%3.2%5.3 $32.03 3/15/2021617,200 shares $18.84 million +5.6%3.0%4.9 $30.52 2/26/2021584,500 shares $21.15 million +23.4%2.9%4.9 $36.18 2/12/2021473,800 shares $18.16 million -3.4%2.3%3.6 $38.33 1/29/2021490,400 shares $17.51 million -27.2%2.4%3.3 $35.71 1/15/2021673,900 shares $26.02 million No Change3.3%4.2 $38.61 HRMY Short Interest - Frequently Asked Questions What is Harmony Biosciences' current short interest? Short interest is the volume of Harmony Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,250,000 shares of HRMY short. 7.46% of Harmony Biosciences' shares are currently sold short. Learn More on Harmony Biosciences' current short interest. What is a good short interest ratio for Harmony Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HRMY shares currently have a short interest ratio of 5.0. Learn More on Harmony Biosciences's short interest ratio. Which institutional investors are shorting Harmony Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Harmony Biosciences: Group One Trading LLC, Citadel Advisors LLC, Susquehanna International Group LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Harmony Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.46% of Harmony Biosciences' floating shares are currently sold short. Is Harmony Biosciences' short interest increasing or decreasing? Harmony Biosciences saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 3,250,000 shares, a decrease of 6.9% from the previous total of 3,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Harmony Biosciences' float size? Harmony Biosciences currently has issued a total of 57,387,000 shares. Some of Harmony Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harmony Biosciences currently has a public float of 43,540,000 shares. How does Harmony Biosciences' short interest compare to its competitors? 7.46% of Harmony Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Harmony Biosciences: TG Therapeutics, Inc. (16.90%), Legend Biotech Co. (5.49%), Sarepta Therapeutics, Inc. (7.51%), ADMA Biologics, Inc. (5.82%), Blueprint Medicines Co. (9.08%), Verona Pharma plc (10.22%), Nuvalent, Inc. (14.61%), Axsome Therapeutics, Inc. (11.68%), Grifols, S.A. (0.88%), Cytokinetics, Incorporated (12.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Harmony Biosciences stock? Short selling HRMY is an investing strategy that aims to generate trading profit from Harmony Biosciences as its price is falling. HRMY shares are trading up $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harmony Biosciences? A short squeeze for Harmony Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HRMY, which in turn drives the price of the stock up even further. How often is Harmony Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRMY, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies TG Therapeutics Short Interest Legend Biotech Short Interest Sarepta Therapeutics Short Interest ADMA Biologics Short Interest Blueprint Medicines Short Interest Verona Pharma Short Interest Nuvalent Short Interest Axsome Therapeutics Short Interest Grifols Short Interest Cytokinetics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HRMY) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRMY Stock Free HRMY Stock Alerts